Ocular Therapeutix (NASDAQ:OCUL) reported quarterly earnings results on February 05, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.29, beating the consensus estimate of $-0.33 by $0.04 per share. Revenue came in at $13.2M, missing the estimate of $15.7M.
Ocular Therapeutix's stock moved following the earnings release. The stock currently trades at $9.16 with a market capitalization of $2.5B.
